Crestwood Capital Management’s Astera Labs ALAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALAB
Crestwood Capital Management's ALAB Position: Q2 2026 in Review
Crestwood Capital Management reduced its Astera Labs (ALAB) stake by 5.8% in Q2 2026, selling an estimated $319K and leaving 19,717 shares worth $9.52M. The position accounts for 6.24% of the portfolio, ranked #8.
Crestwood Capital Management first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.
- Crestwood Capital Management held 19,717 shares of Astera Labs worth $9.52M as of Q2 2026.
- Crestwood Capital Management sold 1,203 Astera Labs shares in Q2 2026, an estimated $319K.
- Astera Labs made up 6.24% of Crestwood Capital Management's portfolio in Q2 2026, its #8 holding.
- Crestwood Capital Management first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
- 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.
Based on Crestwood Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.